Anterior lumbar interbody fusion with beta-tricalcium phosphate in comparison to bone marrow asspirate as bone graft substitute: A prospective clinical study in 50 patients

Putzer, David; Lechner, Ricarda; Kobel, Christian; Liebensteiner, Michael; Bach, Christian; Thaler, Martin

Links

[dx.doi.org] | PDF

Tools

Export citation

Search in Google Scholar

Anterior lumbar interbody fusion with beta-tricalcium phosphate in comparison to bone marrow asspirate as bone graft substitute: A prospective clinical study in 50 patients

Published in 2016 by David Putzer, Ricarda Lechner, Christian Kobel, Michael Liebensteiner, Christian Bach, Martin Thaler

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Abstract

Objectives: Bone graft substitutes have been successfully used in posterolateral lumbar fusion, anterior cervical fusion and animal studies, but to date no study has been conducted to assess the safety and efficacy of beta-tricalcium phosphate in instrumented ALIF fusion. In this prospective one-year[for full text, please go to the a.m. URL] ; SeriesInformation ; Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2016)